Literature DB >> 20165943

The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen.

Clinton E Canal1, Uade B Olaghere da Silva, Paul J Gresch, Erin E Watt, Elaine Sanders-Bush, David C Airey.   

Abstract

RATIONALE: Hallucinogenic serotonin 2A (5-HT(2A)) receptor partial agonists, such as (+ or -)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride (DOI), induce a frontal cortex-dependent head-twitch response (HTR) in rodents, a behavioral proxy of a hallucinogenic response that is blocked by 5-HT(2A) receptor antagonists. In addition to 5-HT(2A) receptors, DOI and most other serotonin-like hallucinogens have high affinity and potency as partial agonists at 5-HT(2C) receptors.
OBJECTIVES: We tested for involvement of 5-HT(2C) receptors in the HTR induced by DOI.
RESULTS: Comparison of 5-HT(2C) receptor knockout and wild-type littermates revealed an approximately 50% reduction in DOI-induced HTR in knockout mice. Also, pretreatment with either the 5-HT(2C) receptor antagonist SB206553 or SB242084 eradicated a twofold difference in DOI-induced HTR between the standard inbred mouse strains C57BL/6J and DBA/2J, and decreased the DOI-induced HTR by at least 50% in both strains. None of several measures of 5-HT(2A) receptors in frontal cortex explained the strain difference, including 5-HT(2A) receptor density, Galpha(q) or Galpha(i/o) protein levels, phospholipase C activity, or DOI-induced expression of Egr1 and Egr2. 5-HT(2C) receptor density in the brains of C57BL/6J and DBA/2J was also equivalent, suggesting that 5-HT(2C) receptor-mediated intracellular signaling or other physiological modulators of the HTR may explain the strain difference in response to DOI.
CONCLUSIONS: We conclude that the HTR to DOI in mice is strongly modulated by 5-HT(2C) receptor activity. This novel finding invites reassessment of hallucinogenic mechanisms involving 5-HT(2) receptors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20165943      PMCID: PMC2868321          DOI: 10.1007/s00213-010-1784-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  55 in total

1.  Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus.

Authors:  K J Damjanoska; B A Heidenreich; G H Kindel; D N D'Souza; Y Zhang; F Garcia; G Battaglia; W A Wolf; L D Van de Kar; N A Muma
Journal:  J Pharmacol Exp Ther       Date:  2004-02-19       Impact factor: 4.030

2.  Serotonin 5- HT (2C) receptor knockout mice: autoradiographic analysis of multiple serotonin receptors.

Authors:  Juan F López-Giménez; Laurence H Tecott; José M Palacios; Guadalupe Mengod; M Teresa Vilaró
Journal:  J Neurosci Res       Date:  2002-01-01       Impact factor: 4.164

3.  Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice.

Authors:  Randy L Smith; Robert J Barrett; Elaine Sanders-Bush
Journal:  Psychopharmacology (Berl)       Date:  2002-12-10       Impact factor: 4.530

4.  Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies.

Authors:  J F López-Giménez; M T Vilaró; J M Palacios; G Mengod
Journal:  J Comp Neurol       Date:  2001-01-22       Impact factor: 3.215

5.  Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists.

Authors:  S P Vickers; N Easton; C S Malcolm; N H Allen; R H Porter; M J Bickerdike; G A Kennett
Journal:  Pharmacol Biochem Behav       Date:  2001 Jul-Aug       Impact factor: 3.533

6.  Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat.

Authors:  A Gobert; J M Rivet; F Lejeune; A Newman-Tancredi; A Adhumeau-Auclair; J P Nicolas; L Cistarelli; C Melon; M J Millan
Journal:  Synapse       Date:  2000-06-01       Impact factor: 2.562

7.  Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.

Authors:  Philippe De Deurwaerdère; Sylvia Navailles; Kelly A Berg; William P Clarke; Umberto Spampinato
Journal:  J Neurosci       Date:  2004-03-31       Impact factor: 6.167

Review 8.  Hallucinogens.

Authors:  David E Nichols
Journal:  Pharmacol Ther       Date:  2004-02       Impact factor: 12.310

9.  Differential activation of Gq/11 and Gi(3) proteins at 5-hydroxytryptamine(2C) receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking.

Authors:  Didier Cussac; Adrian Newman-Tancredi; Delphine Duqueyroix; Valérie Pasteau; Mark J Millan
Journal:  Mol Pharmacol       Date:  2002-09       Impact factor: 4.436

10.  Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study.

Authors:  Boris B Quednow; Anne Schmechtig; Ulrich Ettinger; Nadine Petrovsky; David A Collier; Franz X Vollenweider; Michael Wagner; Veena Kumari
Journal:  Biol Psychiatry       Date:  2009-06-28       Impact factor: 13.382

View more
  44 in total

1.  Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  J Neurosci       Date:  2010-10-06       Impact factor: 6.167

Review 2.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345

Review 3.  Functional selectivity in GPCR heterocomplexes.

Authors:  J González-Maeso; S C Sealfon
Journal:  Mini Rev Med Chem       Date:  2012-08       Impact factor: 3.862

4.  Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.

Authors:  Boris B Quednow; Michael Kometer; Mark A Geyer; Franz X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

5.  The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.

Authors:  Theresa M Carbonaro; Amy J Eshleman; Michael J Forster; Kejun Cheng; Kenner C Rice; Michael B Gatch
Journal:  Psychopharmacology (Berl)       Date:  2014-07-03       Impact factor: 4.530

6.  Dysregulated corticostriatal activity in open-field behavior and the head-twitch response induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine.

Authors:  Claudia Rangel-Barajas; Ana María Estrada-Sánchez; Scott J Barton; Robert R Luedtke; George V Rebec
Journal:  Neuropharmacology       Date:  2016-11-02       Impact factor: 5.250

7.  Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice.

Authors:  John P Dougherty; Vincent J Aloyo
Journal:  Psychopharmacology (Berl)       Date:  2011-02-22       Impact factor: 4.530

8.  Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system.

Authors:  Terrell Holloway; José L Moreno; Adrienne Umali; Vinayak Rayannavar; Georgia E Hodes; Scott J Russo; Javier González-Maeso
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

9.  Neuronal ablation of p-Akt at Ser473 leads to altered 5-HT1A/2A receptor function.

Authors:  Jeremy M Veenstra-Vanderweele; Aurelio Galli; Christine Saunders; Michael Siuta; Sabrina D Robertson; Adeola R Davis; Jennifer Sauer; Heinrich J G Matthies; Paul J Gresch; David Airey; Craig W Lindsley; John A Schetz; Kevin D Niswender
Journal:  Neurochem Int       Date:  2013-09-30       Impact factor: 3.921

Review 10.  Animal models of serotonergic psychedelics.

Authors:  James B Hanks; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2012-09-24       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.